Clorox (CLX) Director Stephanie Plaines Receives Deferred Stock Units

What Happened
Stephanie Plaines, a director of Clorox Co. (CLX), received two awards of Deferred Stock Units (DSUs) under the company's director compensation plan. On 2026-05-08 she was awarded 103.94 DSUs and on 2026-06-30 she was awarded 288.139 DSUs, for a total of 392.079 DSUs. Each award shows an acquisition price of $0.00 because these were granted as compensation (derivative awards), not purchased on the open market.

Key Details

• Transaction dates and amounts:
  • 2026-05-08 — 103.94 DSUs (code A, $0.00 acquisition price)
  • 2026-06-30 — 288.139 DSUs (code A, $0.00 acquisition price)
• Total awarded during the reporting period: 392.079 DSUs.
• Shares owned after transaction: not specified in the provided filing.
• Footnotes in the filing:
  • F1: 1-for-1 conversion (DSUs convert 1-for-1 to shares)
  • F2: DSUs include units acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan
  • F3: DSUs will be settled 100% in Clorox stock upon the director’s retirement or termination of service
  • F4: DSUs were received in lieu of quarterly director fees
• Filing date: Form filed 2026-07-02 (covers period ending 2026-06-30). The filing does not indicate delinquency.

Context
These entries are non-cash compensation for a director (awards/deferrals), not open-market purchases or sales, and are commonly used to defer fees and receive future equity. DSUs signal deferred pay that will convert to shares later (per F3) and do not, by themselves, indicate a buy/sell market sentiment.